Market Overview:
The animal healthcare market covers veterinary medicines such as vaccines, parasiticides, antibiotics, and other animal care products such as medical feed additives, feed supplements, and functional ingredient. Rise in adoption of pets such as dogs and cats along with growing meat and dairy consumption has been boosting the demand for various animal healthcare products globally. Advancements in animal disease diagnosis and treatment along with growing pet humanization further support the market growth.
Market Dynamics:
Rising pet adoption across the globe is a major factor driving the animal healthcare market growth. According to the latest APPA National Pet Owners Survey conducted in the U.S in 2017, around 85 million households own a pet, which account for nearly 68% of total households in the country. This shows high penetration and demand for animal healthcare and nutrition products. Additionally, growing consumption of animal-derived food products such as meat and dairy has been propelling the demand for animal health products to prevent infectious diseases in livestock. Furthermore, increasing investments by key players for developing novel veterinary products through R&D activities are expected to create lucrative opportunities over the forecast period. However, stringent regulations pertaining to the approval and use of animal healthcare drugs may hamper the market growth.
The global Animal Healthcare Market Growth is estimated to be valued at US$ 50.45 Bn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: The animal healthcare market has strong presence of leading players developing innovative products to cater to rising demand. Their extensive R&D capabilities allow development of advanced drugs and vaccines. Furthermore, increasing pet ownership and growing awareness about animal health is driving demand for animal healthcare products.
Weakness: High costs associated with developing new drugs and bringing them to market pose challenges. Long approval timelines for new products can delay revenue generation. Lack of standards and regulations in some emerging countries also acts as a hurdle.
Opportunity: Untapped opportunities exist in developing regions owing to growing pet population and rising disposable incomes. Growing focus on preventive healthcare rather than curative will boost demand for vaccines and nutritional products. Furthermore, technological advancements allow development of advanced veterinary equipment and point-of-care devices.
Threats: Stringent regulations surrounding testing and manufacturing of animal drugs increases cost of operations. Supply chain disruptions due to COVID-19 pandemic impacted production and distribution capabilities. Rising prevalence of zoonotic diseases also poses risks.
Key Takeaways
The global animal healthcare market is expected to witness high growth, exhibiting CAGR of 5.1% over the forecast period, due to increasing pet ownership and growing awareness about animal health. Growing humanization of pets coupled with rising per capita expenditure on pet care will drive demand.
Regional analysis: North America dominates the global market currently owing to high per capita expenditure on pet care in countries like US and Canada. Asia Pacific is expected to witness fastest growth during the forecast period led by India and China. Rising pet adoption coupled with growing animal protein consumption in the region will propel the regional market.
Key players operating in the animal healthcare market are Bayer AG, Boehringer Ingelheim GmbH, Cargill Inc., Ceva Santé Animale, Eli Lilly and Company, DSM, Merck & Co., Inc., Novartis AG, Nutreco N.V., Sanofi S.A., SeQuent Scientific Ltd., Virbac S.A., Vétoquinol S.A., Zoetis Inc. These companies focus on investing in product development and strategic acquisitions to consolidate their market share.